Commitments and Contingencies (Details) $ in Millions |
1 Months Ended | 12 Months Ended | |
---|---|---|---|
Jul. 31, 2012
claim
|
Dec. 31, 2015
USD ($)
shares
|
Dec. 31, 2014
USD ($)
|
|
Business Acquisition, Contingent Consideration [Line Items] | |||
Contingent consideration | $ 54.4 | $ 71.6 | |
Issuance of common stock | shares | 1,194,337 | ||
Number of claims included in post-payment audit | claim | 183 | ||
Fixed purchase provisions | $ 48.3 | ||
Accrued Expenses | |||
Business Acquisition, Contingent Consideration [Line Items] | |||
Contingent consideration | 22.2 | 27.4 | |
Other Long-term Liabilities | |||
Business Acquisition, Contingent Consideration [Line Items] | |||
Contingent consideration | 32.3 | $ 44.2 | |
OPKO Renal | |||
Business Acquisition, Contingent Consideration [Line Items] | |||
Payments on loss contingency | $ 20.0 |
X | ||||||||||
- Definition Number of Medicare Claims Included in Post-Payment Review Audit No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of payments made reducing loss contingency liability. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier. No definition available.
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|